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1. Introductiori
Recently several studies have been published which 
describe the faithful translation of animal messenger 
and viral-RNA in eukaryotic cross systems [1—12].
Although stimulation of amino acid incorporation 
by viral RNA or eukaryotic messengers in bacterial 
cell-free systems has been reported, reliable translation 
has only been described incidentally [13—19].
We compared the translation of eukaryotic- and 
oncogenic viral-RNA’s in the cell-free system of £  coli 
with that of the reticulocyte lysate. Our results provide 
evidence that in the bacterial system the viral RNA’s 
are translated into several distinctpolypeptides, where- 
as no indication for the translation of eukaryotic mes­
sengers could be obtained. Moreover, addition of the 
viral RNA’s to the mammalian systems described, ap- 
peared not to result in translation.
2. Materials and methods
Rauscher leukemia virus (RLV). was isolated from 
the plasma of leukemie mice as described [20]. Purified 
mouse mammary tumor virus (MTV) from mammary 
tumors of (C3H/HeA X 020)Fj mice was a generous 
gift of Dr. P. Hageman. After incubation of the virus 
with pronase in the presence of SDS the viral RNA’s 
were extracted with chloroform—phenol [21, 22]. The 
60 S component of RLV-RNA was isolated by centri-
fugation in isokinetic glycerol gradients (15.0-30.21 
w/v). Denaturation of RNA was performed in 3 mM 
KC1 for 3 min at 65° [23]. After heating and rapid 
cooling the RNA preparations were immediatëly tes 
ed for their messenger activity. Globin 9 S and a-cr> 
tallin 14 S mRNA were a gift of Dr. A. Berns. Mono 
layers of mouse spleen- and thymus-cells (JLS-V5) 
were used for the propagation of radioactive-labeled 
RLV. The JLS-V5 cell line was a generous gift of Dr 
W. Schafer. The preparation of phage M12 RNA anc 
of the cell-free system of E. coli has previously been 
described [24]. The incubation mixture contained p 
ml: 50 nmoles of each of the added unlabeled aminc 
acids, 10 jumoles magnesium acetate, 50 jumoles Tris 
HC1, pH 7.8,70 jumoles NH4C1, 8 /zmoles 2-mercapt 
ethanol, 0.25 mgE. coli tRNA, 5 jumoles ATP, 0.3 
jumoles GTP, 5 Mmoles PEP, 8 ng pyruvate kinase, ar 
0.24 ml of pre-incubated S-30. The amounts of RN/ 
and radioactive label added to the system are given i 
the legend of table 1. After 30 min of incubation at 
37°, 10 jul aliquots from the incubation mixture wer 
removed for the estimation of total protein synthesii 
by precipitation with TCA. The remainder was treati 
with pancreatic RNAase and analyzed by electropho 
resis on 12.5% SDS—polyacrylamide gels [25].
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3. Results and discussion
3.1. E ffect ofviral RNA and eukaryotic mRNA on 
amino acid incorporation
Addition of either RLV-RNA or MTV-RNA to the 
cell-free system of E. coli resulted in a significant stim- 
ulation of the amino acid incorporation (table 1). When 
equal amounts of RLV- and MTV-RNA were tested, the 
stimulatory effect of the latter was always more pro- 
nounced. An even higher stimulation could be obtain- 
ed if instead of total RLV-RNA the purified 60 S RNA 
component was added to the system. This is probably. 
due to an inhibitory effect of the low molecular weight 
viral RNA (4—5 S), present in the virion, on the transla- 
tion of 60 S RLV-RNA. Evidence for this assumption 
was derived from the fact that this low molecular 
weight RNA fraction also inhibited the translation of 
phage M12 RNA (cf. [26]). Denaturation of RLV- 
RNA consistently resulted in an additional stimulation 
of the amino acid incorporation, while denaturation
Table 1
Stimulation o f amino acid incorporation by viral RNA and 
eukaryotic RNA preparations in the cell-free system of E. coli.
Exp. I Exp. II
RNA added [14C]amino RNA added [35S]methionine
acid (cpm (cpm incorporated
incorporated)
None 558 None 5820
Phage M l2 12,693 'Phage M12 138,866
RLV 1058 (2010)* RLV 8784 (14,398)
RLV 60 S 1928 (2749) Globin 9 S 8960 (10,102)
MTV 2033 (2386) a-crystallin
Ribosomal 14 S 6506 (7290)
18 S 604
Ribosomal
28 S 613
To each 60 jul incubation mixture, in experiment 1 ,4 Mg RNA 
and 5 MCi [14C]amino acid mixture (54 Ci/mg-atom of carbon) 
was added. In experiment II, to each 60 jul incubation mixture 
5 mg RNA and 8 nCi [3sS]methionine (32 Ci/mmole) was added. 
After 30 min of incubation at 37° the reaction was terminated 
by the addition o f  60 m1 of 0.025 M EDTA and TCA precipit- 
able radioactivity was determined in 10 m1 aliquots o f the incu­
bation mixture.
* Values obtained after denaturation o f the RNA are given in 
parentheses.
of MTV-RNA was much less effective. For comparison 
the effect of several distinct eukaryotic mRNA prepa­
rations on the amino acid incorporation was studied. 
Addition of globin 9 S mRNA resulted in a stimulation 
of the amino acid incorporation which could be enhanc 
ed by denaturation. The effect of lens 14 S mRNA, 
coding for the A2 -chain of a-crystallin, was almost 
negligible.
No significant stimulation could be observed after 
addition of either 18 S or 28 S ribosomal RNA to the 
cell-free system.
3.2. Analysis o f  the in vitro products by SDS polyacryl- 
amide gel electrophoresis
From the results presented in fïg. 1 A it can be con- 
cluded that addition of native RLV-RNA to the cell- 
free system gives rise to the synthesis of a number of 
distinct polypeptides. Co-electrophoresis of these poly- 
peptides with the proteins derived from the virion in- 
dicated that at least those migrating in the low molec­
ular weight range (slice no. 52—71) coincide with the 
native viral proteins (fig. 1 B). Furthermore additional 
polypeptides are synthesized which migrate in the 
30,000 dalton region (slice no. 32—40). The effect of 
denaturation of RLV-RNA on the translation is strik- 
ing. This resulted in the appearance of a high molec­
ular weight polypeptide (slice no. 24-27) which is 
only present in trace amounts in the control experi­
ment. In order to obtain more accurate data about the 
size and number of the synthesized polypeptides, auto- 
radiographic analysis on dried gels was performed. In 
fig. 2 A, the autoradiogram of the polypeptides syn­
thesized under the direction of denatured RLV-RNA 
is shown (b). For comparison, the gel pattern of label- 
ed viral proteins is also depicted (c). It may be conclud- 
ed that denatured RLV-RNA mainly gives rise to the 
synthesis of two polypeptides, RE0 and RE2 , with 
molecular weights of approx. 45,000 and 15,000 dal- 
tons, respectively. The electrophoretic mobility of the 
polypeptide RE2 is identical to that of the native pro- 
tein R2. It might be possible that the polypeptide RE0 
is identical to one of the minor viral proteins present 
in the 45,000 daltons region. No clear indication could 
be obtained whether a polypeptide of the same size as 
the viral protein Ri (gs 1) was synthesized. Further­
more several faint bands are visible of which at least 
some seem to have no corresponding polypeptide syn-
349
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slice num ber slice num ber
Fig. 1. SDS gel analysis o f the polypeptides synthesized under direction o f RLV-RNA. A) Polypeptides synthesized in the absence 
(o . - o - - o) and presence ( • — • — • )  of RLV-RNA. B) Comparison by co-electrophoresis of the polypeptides synthesized in vitro 
under the direction o f  denatured RLV-RNA ( • — • — • )  with the viral proteins labeled with [ 14C] amino acids (o - - o - - o). Incu- 
bation in the presence o f [3H]histidine. After electrophoresis the gels were sliced in 1 mm sections. To measure the radioactive 
labels separately the dried gel slices were processed with the aid o f  the Tri-Carb Sample Oxidizer (Packard Model 305).
thesized in the endogenous system.
As the RNA present in the RLV virion consists of 
several RNA species, experiments were performed to 
investigate whether there exists a' difference between 
the polypeptides synthesized under the direction of 
total RNA and the purified 60 S RNA component. 
Analysis of the in vitro products showed that both 
RNA preparations directed the synthesis of the same 
polypeptides (fig. 2 B, a—c). From these results it may 
be concluded that the RNA component sedimenting 
in the 60 S region contains all the genetic information
necessary to code for the polypeptides synthesized in 
the in vitro system.
Evidence for the reliability of the in vitro transla- 
tion of RLV-RNA can be derived from the observation 
that under direction of RNA isolated from the non- 
related mouse mammary tumor virus (MTV) quite dif­
ferent polypeptides are synthesized. MTV-RNA directs 
the synthesis of at least one polypeptide MEt which 
coincides with one of the native MTV proteins (P6), 
(fig. 3 A, a—c). This polypeptide migrates slightly 
faster than the RLV-RNA directed polypeptide RE2.
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a b c  a b c d e
Fig. 2. Autoradiograms o f the polypeptides synthesized under the direction of RLV-RNA and separated by SDSgelelectrophoresis.
A) Products o f  the endogenous E, coli system (a); with denatured RLV-RNA (b); RLV proteins labeled with [14C] amino acids (c).
B) Productsof the endogenous E. coli system (a); with RLV-RNA (b); with denatured RLV-RNA (c); with the 60 S RLV-RNA com­
ponent (d); with the denatured 60 S RLV-RNA component (e). Incubation in the presence o f [ 14C] amino acids.
RE0
a
ME,
1
1 1
a b c  d e f  a h c d e f g
Fig. 3. A) Autoradiograms of the polypeptides synthesized under the direction o f MTV- or RLV-RNA and separated by SDS gel 
electrophoresis. Native MTV proteins stained with Coomassie blue (a); in vitro system supplemented with MTV-RNA (b); with de­
natured MTV-RNA (c); without RNA (d); with RLV-RNA (e); with denatured RLV-RNA (f). Incubation in the presence o f [14C] 
amino acids. B) Autoradiograms of the polypeptides synthesized under the direction o f  globin 9 S and a-crystallin 14 S mRNA. 
Products o f the endogenous E, coli system (a); with globin 9 S mRNA (b); with denatured globin 9 S mRNA (c); with a-cryatallin
14 S mRNA (d); with denatured a- crystallin 14 S mRNA (e); with native RLV-RNA (f); with denatured RLV-RNA (g). a stands 
for a-crystallin, g stands for globin. Incubation in the presence o f [35S]methionine.
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Denaturation of MTV-RNA does not result in the syn­
thesis of an additional polypeptide (c) as has been ob- 
served in the case of RLV-RNA (f). There is a striking 
discrepancy between the distribution of radioactivity 
of polypeptides synthesized under the direction of 
MTV-RNA as compared with those synthesized under 
the direction of RLV-RNA (compare b, c with e and f).
Furthermore, in case of MTV-RNA a pronounced 
synthesis of polypeptides which migrated with the 
buffer-front could be observed (b, c). The reason for 
this may be that, although there is a high rate of initi- 
ation, the completion of polypeptides is inefficient.
In order to examine whether eukaryotic mRNA 
preparations are faithfully translated we studied the 
effect of addition of a-crystallin 14 S and globin 9 S 
mRNA to the E. coli cell-free system. From fig. 3 B 
it may be concluded that both mRNA fractions do 
not give rise to the synthesis of their encoded proteins 
(b—e). Only low molecular wèight polypeptides seem 
to be synthesized. As suggested above this may be due 
to the fact that proteins are initiated but, for reasons 
still unknowh, not completed. In this connection it 
should be mentioned that under conditions in which 
globin- and a-crystallin-mRNA are translated very 
efficiently in a reticulocyte cell-free system and in 
oocytes, until now in both systems no evidence could 
be obtained for the translation of RLV-RNA (experi- 
ments in collaboration with Dr. J.B. Gurdon, Unpub- 
lished). In the reticulocyte system only a strong inhibi- 
tion of globin synthesis, up to 85%, could be observed. 
Although a 0.5 M KCl-wash derived from polysomes 
of leukemie spleens stimulated the endogenous globin 
and a-crystallin synthesis, no indication could be ob­
tained whether this fraction has a positive effect on the 
translation of RLV-RNA as well.
From our results the conclusion seems to be justi- 
fïed that in the cell-free system of E. coli under the 
direction of the different viral RNA preparations 
tested at least some virus-specific polypeptides are 
synthesized. No specifïc polypeptides, however, are 
synthesized when this cell-free system is programmed 
with eukaryotic mRNA’s.
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INHIBITORY EFFECT OF RIFAMPICIN ON RAUSCHER-VIRUS- 
INDUCED MURINE LEUKAEMÏA
by
A. L. J. G i e l k e n s  1, J. Th. M. B u r g h o u t s  2 and H . B l o e m e n d a l
D epartm en t o f  B iochem istry , U n iversity  o f  N ijm egen, N ijm egen, The N etherlands
Rifam picin has a  m a rk ed  inh ibitory effect on Rauscher-virus-induced leukaem ia. 
Up to  9 0 %  inhibition o f  sp lenom egaly  can be achieved when the drug is adm in istered  
im m ediately a fter  infection. I t  is  su ggested  that these resu lts m a y  have im plications  
f o r  a  ra tional leukaem ia therapy.
All the RNA tumour viruses contain an 
enzyme that transcribes RNA to DNA (Schlom 
e t a l.,  1971a). This finding provides direct 
evidence for Temin’s hypothesis that RNA 
tumour viruses need a DNA intermediate for 
virus replication (Temin, 1964). Synthesis of 
new DNA, possibly virus-specific, appears in 
the cytoplasm of cells within a short time after 
infection (Hatanaka e t  a l., 1971). Chronically 
infected cells do not show such a DNA syn­
thesis. Whether the newly-formed DNA becomes 
integrated in the host cell genome remains to be 
determined.
An RNA-dependent DNA polymerase has 
been detected in lymphoblasts of patients with 
acute and chronic lymphoblastic leukaemia 
(Gallo e t a l., 1970, and Penner e t a l., 1971). 
DNA polymerase activity seems to be present 
in a particulate fraction of plasma from patients 
with chronic lymphatic leukaemia (Kiessling 
e t a l., 1971). Reserve transcriptase activities have 
also been observed in a cell line derived from 
leukocytes of a patiënt with a myeloid leukaemia 
(Ackermann e t a l., 1971) and in virus-like 
particles isolated from human milk (Schlom 
e t  a l.,  19716).
In v itro  the RNA-dependent DNA poly­
merase can be inhibited partly by rifampicin and 
to a much greater extent by rifampicin derivatives,
with modified aminopiperazine side chains and 
streptovaricins (Gallo e t a l., 1970; Gurgo e t al., 
1971; Broekman e t a l., 1971). Rather contra- 
dictory results have been published concerning 
the effect of rifampicin and rifampicin derivatives 
on virus production and cell transformation 
after infection of tissue culture cells with an RNA 
tumour virus (Diggelmann and Weissmann, 
1969; Robinson and Robinson, 1971; Richert 
and Balduzzi, 1971; Calvin e t a l., 1971; Carter 
e t al., 1971; Lancini e t a l., 1971). This article 
describes the inhibitory effect of rifampicin on 
Rauscher-virus-induced leukaemia in vitro. The 
Rauscher virus elicits primarily a rapid prolifer- 
ation of erythroblastic elements which results 
in spleen enlargement. The rate of splenomegaly 
can be used as an indicator of the progression 
of the disease (Rauscher and Allen, 1964). 
Drug-induced inhibition of spleen enlargement 
can be considered as an easily-detectable mani- 
festationof a therapeutic effect (Chirigos, 1963).
MATERIAL AND METHODS
In all experiments mentioned below, 3-week- 
old random-bred female Swiss mice were used. 
Mice were infected intraperitoneally with 0.1 ml 
of a 10% spleen homogenate as described before 
(Burghouts e t a l., 1970). Unless otherwise 
indicated, treatment with rifampicin commenced
Received: December 29, 1971.
1 A. L. J. Gielkens is a fellow o f  the Koningin Wilhelmina Fonds (Royal Cancer Foundation).
4 Present address: Department o f Medicine, St. Radboud Hospital, University o f  Nijmegen, Nijmegen, 
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7 days after infection. Rifampicin powder 
(Lepetit, Milan, Italy) in various amounts as 
described in the “ Results ” section was mixed 
with 2.5 g of pulverized mouse feed granules per 
mouse. Control animals received the same 
amount of feed. Mice were killed 4 weeks after 
infection, i.e., 3 weeks after commencing treat­
ment. The spleen weight was determined imme- 
diately.
RESULTS
The relation between spleen weight and 
appropriate time intervals after infection is 
demonstrated in Figure 1. Already 7 days after 
infection a marked increase in spleen weight 
can be observed. This means that treatment 
was started when all mice had overt leukaemia.
The results of some experiments performed 
with rifampicin are given in Table I. It can be 
seen from this Table that administration of
5 mg of rifampicin, 7 days after Rauscher virus 
infection, results in a reduction of spleen enlarge- 
ment of 61.7%. This experiment was repeated 
five times. In all these different experiments 
the inhibitory effect of the drug (approximately 
50-60%) was obvious. The inhibition of spleen 
enlargement is even more pronounced when 
treatment is started 4 days (85.1%) or immedi­
ately (90.3%) after infection. We have evidence 
that pretreatment of the mice with rifampicin 
for 7 days does not result in an enhanced effect.
The inhibitory effect of rifampicin depends 
on the amount of the drug used in each exper­
iment (Fig. 2). A higher concentration finally 
results in a lower spleen weight. The drug con­
centration generally used (5 mg rifampicin/ 
mouse/24 h) was not toxic since uninfected
d a y s  a f te r  infection
F ig u r e  1
Relation between spleen weight and time after infection 
Random-bred Swiss mice were infected with the 
Rauscher virus as described in the text. Uninfected 
mice served as Controls. At appropriate time intervals 
mice were killed with ether anaesthesia and their 
spleens were weighed immediately. Each point 
represents the average spleen weight o f at least 
10 mice. o :  spleen weights o f  Rauscher-virus- 
infected mice. A : spleen weights o f uninfected control 
mice.
control animals which were treated similarly 
had exactly the same spleen weights and body 
weights as the untreated control mice. In mice 
the LD50 of the drug per os was approximately
1,400 mg/kg body weight (Gruppo Lepetit 
S.p.A. Milan, Italy, unpublished results). In 
our experiments 1,250 mg/kg body weight given 
in a single dose orally and mixed with food was 
not lethal. For comparison, the effect of tetra­
cycline was also studied. The latter treatment 
did not reveal any inhibitory effect.
TABLE i
INHIBITORY EFFECT O F RIFAM PICIN ON SPLEEN ENLARGEM ENT IN LEUKAEM IC M ICE 1
Number 
o f mice Treatment mg drug/mouse/24h
D uration of 
treatm ent in 
days after 
infection
Average 
spleen weight 
in mg
Standard error 
in mg
Inhibition o f 
splenomegaly (%)
35 None _ 1531.4 176.9 _
9 5 mg Rifampicin 0-28 174.9 40.1 90.3
10 5 mg Rifampicin 4-28 254.3 66.9 85.1
9 5 mg Rifampicin 7-28 604.1 163.2 61.7
1 Random-bred Swiss mice were infected with the Rauscher virus as described in the text. Mice were treated at appropriate dates 
with drugs as specified. A fter 4 weeks the mice were killed by ether anaesthesia and their spleens were weighed immediately. The results 
in this Table are a typical example o f five different experiments performed. Spleens o f uninfected mice o f the same age weighed 30.4 mg.
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F igure 2
Relation between spleen weight and rifampicin con- 
centration during treatment
Four groups o f  random-bred Swiss mice were infec- 
ted with the Rauscher virus as described in the text. 
One week after infection rifampicin in specified 
concentrations was administered to three groups of  
mice. After 4 weeks, all the mice were killed by 
ether anaesthesia and their spleens were weighed 
immediately. Spleens o f the untreated group o f mice 
served as a 100% control. Inhibition o f spleen en- 
largement is dependent on the concentration of  
Rifampicin used for each group o f mice.
DISCUSSION
The influence of rifampicin (an inhibitor of 
the RNA-dependent DNA polymerase in vitro) 
on the development of Rauscher-virus-induced 
leukaemia in vivo was studied. The drug displayed 
an inhibitory effect which was more pronounced 
when treatment was started immediately after 
virus infection. This effect can be explained by 
the assumption that rifampicin prevents the 
infection of (previously) uninfected cells. Cells 
already involved in virus production and trans- 
formation may not be sensitive to the drug. This 
means that rifampicin inhibits either an early 
event, necessary for virus replication and cell 
transformation, i.e., it blocks the reverse trans- 
criptase (thus preventing provirus DNA for- 
mation) or it prevents some of the sequences 
leading to the fixation of the provirus DNA in 
the host cell genome (Richert and Balduzzi, 
1971). Apparently in our experiments the
rifampicin block does not seem to be absolute 
since complete inhibition could not be obtained. 
This may be explained by the fact that rifampicin 
itself is not a potent inhibitor of the RNA- 
dependent DNA polymerase in vitro (Gallo 
et al., 1970; Gurgo et al., 1971). Furthermore 
the route of administration (mixing with food) 
probably does not result in optimal serum 
rifampicin levels during the full 24 h. More 
potent inhibitors of reverse transcriptase AF/AP, 
AF/ABP and AF/ABDP could be tested only 
in rather low concentrations. The preliminary 
results of these experiments indeed indicate an 
inhibitory effect.
As the inhibitory effect of rifampicin in vitro 
is rather low, our results obtained with the 
drug in vivo are surprising. Experiments per- 
formed with streptovaricins, which are more 
potent inhibitors of the reverse transcriptase 
(Broekman et al., 1971; Carter et al., 1971), 
resulted in an inhibition of spleen enlargement 
only for approximately 20% when administered
8 days after infection (Borden et al., 1971). This 
result may probably be ascribed to the low 
absorption rate of the streptovaricin complex 
when administered orally and the duration of 
the treatment (one week). Serum levels of 1-3 
/ig/ml can be obtained with 1,500 mg strep­
tovaricin complex/kg body weight/24 h. In 
our experiments with 5 mg rifampicin/mouse/ 
24 h (approximately 250 mg/kg body weight/ 
24 h) we obtained serum levels of 100yug/ml. Our 
results also admit an alternative explanation 
recently proposed by Vaheri and Hanafusa 
(1971). The authors suggest that rifampicin may 
be more toxic to transformed cells than to 
normal cells.
If the effect observed is as selective as it seems 
to be, then it may have important implications 
for a rational leukaemia therapy.
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EFFET INHIBITEUR DE LA RIFAMPICINE SUR LA 
LEUCÉMIE MURINE INDUITE PAR LE VIRUS DE RAUSCHER
La rifampicine a des effets inhibiteurs prononcés sur la leucémie induite par le 
virus de Rauscher. L'inhibition de la splénomégalie peut atteindre 90 % si le produit est 
administré tout de suite après Vinfection. Nous pensons que ces résultats peuvent avoir 
des implications quant a un traitement rationnel de la leucémie.
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Evidence for a “Non-genetic” Origin of the A l Chains of a-Crystallin
I t  is now firmly established th a t a-crystallin is an aggregate of different polypeptides. 
Calf lens a-crystallin consists of basic and the acidic polypeptide chains (Bloemendal, 
1969) which separate on basic urea-polyacrylamide gels into aA l, «A2, xB l and aB2 
(Bloemendal, Berns, Zweers, Hoenders and Benedetti, 1972).
Schoenmakers and Bloemendal (1968) were able to show th a t in embryonic calf 
lenses the aA l chain is lacking. ïh is  polypeptide, however, appears gradually with 
increasing age of the embryo. Palmer and Papaconstantinou (1969) confirmed this 
observation and suggested th a t the aA l chain is not formed by de novo synthesis but 
by a chemical or enzymic conversion from aA2. Delcour and Papaconstantinou (1970) 
demonstrated th a t in fiber cells all four chains are present whereas adult lens epithelial 
cells contain mainly aA2 and aB2.
Schoenmakers, Gerding and Bloemendal (1969) demonstrated th a t both acidic 
chains have an identical amino acid content. Peptide mapping after chymotryptic 
digestion of the A chains revealed the occurrence of one “difference-peptide” of similar 
amino acid composition. The difference was ascribed to the fact th a t aA2 had a glut- 
amine or asparagine residue instead of a glutamic acid or aspartic acid in aA l. The 
latter observation has recently been confirmed and extended by analysis of tryptic 
peptides from A l and A2. We have atrong evidence tha t actually a glutamine-glut- 
amic acid conversion is responsible for the difference, in which Gin in position 9 of the 
cysteiné peptide described by Corran and Waley (1971), is involved (van der Ouderaa, 
de Jong and Bloemendal, unpublished data). This difference explains the higher 
mobility of aA l in gel electrophoresis a t alkaline pH. We have recently isolated 
messenger RNA species from calf lens (Bems, de Abreu, van Kraaikamp, Benedetti 
and Bloemendal, 1971). These messengers were precisely translated in two different 
cell-free systems (Berns, Strous and Bloemendal, 1972; Mathews, Osborn, Berns and 
Bloemendal, 1972) and in an in  vivo system (Berns, van Kraaikamp, Bloemendal and 
Lane, 1972).
Our recent results clearly show th a t there is no detectable messenger RNA species 
in calf lens coding for aA l. This finding may explain the preliminary experiments of 
Palmer and Papaconstantinou (1969) who pulse-labeled fetal calf lens with radioactive 
amino acids and found no radioactivity in aA l. The absence of a messenger priming 
the synthesis of aA l in post-natal calf lens renders gene activation as an explanation 
veryunlikely. The possibility, however, th a ta  repression mechanism blocks the transla- 
tion of a messenger coding for the aA l chain cannot be ruled out completely. At any 
ra te  the appearance of aA l in the adult lens can easily be understood in terms of dea- 
midation of one glutamine in the aA2 chain.
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